Cambridge Major Plans $20 Million ExpansionBy
Cambridge Major Laboratories Inc. (CML), a supplier of comprehensive pharmaceutical development and manufacturing services, is investing more than $20 million in its R&D and manufacturing facilities in Germantown, Wisconsin. The project will include a new administrative headquarters as well as an expansion of the company's R&D and manufacturing capacity to service the global pharmaceutical industry. The expansion, which is scheduled to be completed by the end of 2015, is expected to create 75 new jobs over the next three years.
To support the project, the Wisconsin Economic Development Corporation has authorized up to $800,000 in Jobs Tax Credits for the company over the next three years. The actual amount of tax credits awarded will depend upon the number of jobs created during that period. The Wisconsin Department of Workforce Development (DWD) also recently issued its intent to award CML a $400,000 Wisconsin Fast Forward worker training grant. The grant will support the training of more than 250 existing and new employees through a new, industry-specific training program that embeds career development with continuous improvement and learning. The Village of Germantown and Washington County joined forces to provide a $280,000 loan through the county's Attraction Fund that allows for principal forgiveness should CML meet certain jobs and new investment performance criteria. If those criteria are met, the loan will be repaid with revenue generated by an existing Tax Increment District. The county also provided a $200,000 low-interest loan from its County Impact Revolving Loan Fund. In addition, the village provided incentives not to exceed $378,000.
CML recently joined with AAIPharma Services Corp. to form a combined supplier of pharmaceutical development and manufacturing services. With more than 800 employees operating out of seven sites in the US and Europe, the combined capabilities include active pharmaceutical ingredient (API) development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (solid dose and parenteral), packaging, and stability services. Germantown is home to CML's US API development and manufacturing headquarters, which employs about 180 workers in a state-of-the-art, 60,000-square-foot facility. The site has all of the capabilities required to provide API development and API manufacturing services from early pre-clinical to commercial production.